Microenvironment-related biomarkers and novel targets in classical Hodgkin’s lymphoma.
Carlo-Stella C, Santoro A
Biomark Med. 2015 Jul 30;9(8):807-17. doi: 10.2217/BMM.15.30
MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiation.
Crisafulli L
Haematologica. 2019 Feb 21;104(9):1744-1755. doi: 10.3324/haematol.2018.198499
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
Guidetti A
Cancer. 2011 May 12;117(22):5074-84. doi: 10.1002/cncr.26182
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
Ricca I
Leukemia. 19(4):644-51.
Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with defibrotide and recombinant human granulocyte colony-stimulating factor.
Carlo-Stella C
Exp Hematol. 32(1):68-75.
Myelodysplastic syndrome with monosomy 7 in adulthood: a distinct preleukaemic disorder.
Dezza L
Haematologica. 68(6):723-35.
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.
Della Porta MG
Leukemia. 2014 May 20;29(1):66-75. doi: 10.1038/leu.2014.161
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis.
Parenti S
NPJ Precis Oncol. 2021 Feb 4;5(1):4. doi: 10.1038/s41698-021-00144-9
Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages.
Fernández-Mariño I
Drug Deliv Transl Res. 2022 Dec 6;13(7):1896-1911. doi: 10.1007/s13346-022-01265-9
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.
Aiuti A
J Clin Invest. 117(8):2233-40.